Ocular Therapeutix Financial Ratios
NASDAQ: OCULHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ocular Therapeutix ratio analysis
Ocular Therapeutix earned a net margin of -511.9% in FY 2025, down from -303.7% a year earlier. Gross margin was 87.3% compared with a median of 88.0% over the prior 9 years. Return on equity reached -40.6%, meaning Ocular Therapeutix generated -0.41 dollars of profit for every dollar of shareholders' equity.
Debt-to-equity stood at 0.11 versus 0.22 the year before, and the current ratio was 15.39. Valuation ratios use the closing share price on each fiscal year-end date and diluted shares from the income statement; profitability and leverage ratios use reported annual figures. Current valuation multiples are on the statistics page.
Summary generated from market data by MetaCap's automated system. Methodology
Ocular Therapeutix financial ratios (annual)
| Ratio | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Price / sales | 42.60 | 21.76 | 6.09 | 4.20 | 12.23 | 72.26 | 46.59 | 82.55 | 66.69 | 110.08 |
| Price / book | 3.38 | 4.40 | 3.91 | 6.11 | 6.05 | 16.53 | — | 4.58 | 4.90 | 3.99 |
| Gross margin | 87.3% | 91.2% | 91.0% | 91.2% | 89.9% | 88.0% | 45.0% | 76.6% | 76.2% | 76.5% |
| Operating margin | -519.8% | -269.6% | -141.0% | -152.7% | -179.3% | -361.1% | -2,029.9% | -2,970.8% | -3,220.1% | -2,296.0% |
| Net margin | -511.9% | -303.7% | -138.1% | -138.0% | -15.1% | -894.3% | -2,043.3% | -3,014.0% | -3,296.2% | -2,369.0% |
| Free cash flow margin | -417.5% | -213.4% | -130.6% | -123.0% | -153.4% | -312.6% | -1,888.2% | -2,568.6% | -3,053.8% | -1,903.6% |
| Return on equity (ROE) | -40.6% | -61.4% | -88.6% | -200.8% | -7.4% | -204.5% | — | -167.2% | -242.4% | -86.0% |
| Return on assets (ROA) | -32.9% | -42.3% | -32.0% | -47.6% | -3.2% | -59.4% | -109.7% | -82.1% | -114.4% | -59.7% |
| Debt / equity | 0.11 | 0.22 | 0.72 | 0.71 | 0.28 | 0.22 | — | 0.69 | 0.48 | 0.27 |
| Current ratio | 15.39 | 10.66 | 6.66 | 4.13 | 7.26 | 9.23 | 5.00 | 6.14 | 3.23 | 8.42 |
| Revenue growth | -18.5% | 9.0% | 13.5% | 18.3% | 150.1% | 311.7% | 112.4% | 3.5% | 1.9% | 7.8% |